European regulators say they have positively confirmed that the recently recalled MS drug Zinbryta had health risks that outweighed any potential benefits, indicating that causes of severe brain inflammation were impossible to predict.…
A federal jury has ruled in favor of AbbVie in the latest AndroGel bellwether lawsuit to go to trial.…
A new study indicates that Zinbryta side effects were so severe it could have never become a major drug product, raising questions as to why it was approved when there were less dangerous alternatives.…
Amid reports of severe brain inflammation and deaths linked to side effects of Zinbryta, the multiple sclerosis drug was recalled globally in early March 2018. As a result of the drug makers failure to warn about the risk of encephalitis, meningoencephalitis and other problems, Zinbryta lawsuits are being evaluated by product liability lawyers. STATUS OF ZINBRYTA LAWSUITS: Lawyers are evaluating whether financial compensation may be available for individuals who have experienced any of the following complications following use of Zinbryta: Encephalitis Meningoencephalitis Other Sudden Brain Inflammation Wrongful Death >>SUBMIT INFO TO A ZINBRYTA LAWYER<< MANUFACTURERS: AbbVie, Inc. and Biogen, Inc.…
The next AndroGel trial is set for May 7 and will address claims by an Arizona man that the testosterone gel caused him to suffer a pulmonary embolism.…
The retrial of a testosterone lawsuit against the makers of AndroGel has ended in a $3.2 million verdict for a man who says the drug’s side effects caused him to suffer a heart attack.…
The FDA says it will help multiple sclerosis patients transition to other drugs following a Zinbryta recall, and will let it stay on the market until the end of April.…
A new study indicates that testosterone treatment side effects may increase the risk of obstructive sleep apnea.…
A Zinbryta recall has been announced following 12 cases of brain inflammation, including three deaths, linked to use of the multiple sclerosis drug.…
A Zinbryta recall and ban has been recommended in the EU following a dozen reports of serious brain inflammation linked to at least three patient deaths.…
